Insulet
PODD
#1092
Rank
A$27.31 B
Marketcap
$388.97
Share price
-1.49%
Change (1 day)
46.86%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

P/S ratio for Insulet (PODD)

P/S ratio as of March 2025 (TTM): 8.66

According to Insulet's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 14.2. At the end of 2024 the company had a P/S ratio of 8.20.

P/S ratio history for Insulet from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20248.20-8.15%
20238.93-43%
202215.7-6.21%
202116.7-10.38%
202018.628.18%
201914.574.59%
20188.33-3.82%
20178.6646.83%
20165.90-23.28%
20157.69-14.43%
20148.989.01%
20138.2469.7%
20124.85-17.17%
20115.86-19.31%
20107.26-11.04%
20098.1648.78%
20085.49-87.81%
200745.0

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.47-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA
1.48-82.94%๐Ÿ‡บ๐Ÿ‡ธ USA
6.64-23.39%๐Ÿ‡บ๐Ÿ‡ธ USA
4.42-48.94%๐Ÿ‡บ๐Ÿ‡ธ USA
5.47-36.89%๐Ÿ‡บ๐Ÿ‡ธ USA
3.59-58.56%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
16.0 84.57%๐Ÿ‡บ๐Ÿ‡ธ USA